Combo Appears Safe, Effective in High-Risk Intraocular Retinoblastoma The ocular event-free survival rate was 43.2% at 1 year, 31.1% at 2 years, and 29.5% at 5 years.

Carboplatin plus etoposide, with or without focal treatments, may be safe and effective for patients with high-risk intraocular #retinoblastoma.

https://bit.ly/435PgGy

#pedcsm

Our CMO @jrgralow discusses #ASCOQLTY25 research being presented now highlighting the importance of federal funding in cancer #ClinicalTrials — particularly early phase, dose de-escalation, rare cancer, multimodality, and child-focused Tx trials. meetings.asco.org/abstracts-pr...

#pedcsm

Combo Appears Safe, Effective in High-Risk Intraocular Retinoblastoma The ocular event-free survival rate was 43.2% at 1 year, 31.1% at 2 years, and 29.5% at 5 years.

Carboplatin plus etoposide, with or without focal treatments, may be safe and effective for patients with high-risk intraocular #retinoblastoma, according to phase 2 trial results. shorturl.at/aY3Xh #pedcsm #OncSky #MedSky

Childhood Cancer Survivors Have Higher Risk of New Cancers, Death After Age 50 “This study underscores the longer-term late effects among this aging cohort of childhood cancer survivors reaching their sixth and seventh decades of life,” the researchers wrote.

Long-term survivors of childhood #cancer have an increased risk of premature death and developing new cancers and other health conditions after age 50, according to recently published findings. shorturl.at/0ZOmR #pedcsm #OncSky

Diabetes May Increase Risk of Cognitive Impairment in Childhood Cancer Survivors Childhood cancer survivors with diabetes mellitus have an increased risk of neurocognitive impairment, a study suggests.

Childhood #cancer survivors with diabetes mellitus have an increased risk of neurocognitive impairment compared to survivors without diabetes mellitus, according to recent research. shorturl.at/0X3GP #pedcsm

Pediatric patients with diffuse midline gliomas may have better outcomes if they have a more diverse gut microbiome, according to data presented at #ASCO25 by Dr Raoull Hoogendijk of @themaximacenter.bsky.social. #btsm #pedcsm shorturl.at/xDTye

MSK Kids Memorial Sloan Kettering Cancer Center The Department of Pediatrics Grand Rounds Presents 2025 M. Lois Murphy Invited Speaker "Financial Toxicity and Cancer Treatment in America" Fumiko Chino, MD, FASCO Assistant Professor, Radiation Oncology MD Anderson Cancer Center Thursday, April 24th | 8:30a - 9:30a | M - 107

Black and white photo of peds hemonc giant Dr Murphy

It was an honor to return to @mskcancercenter.bsky.social today to honor the mission of Dr M Lois Murphy with a lecture on #FinancialToxicity.

Dr Murphy helped lead care delivery innovations including optimal combination tx for pediatric cancers & spearheading out-patient #pedcsm care.

Pediatric Patient Reported Outcomes (PROs) Following Car T Cell Therapy - Penn Center for Cancer Care Innovation This project employs a pediatric-specific tool to collect patient-reported outcomes on subjective symptoms following CAR T Cell therapy.

PC3I's Allie Barz Leahy is leading a project to use a pediatric-specific patient-reported outcomes (PROs) tool to collect & characterize symptoms #pediatric patients experience after #CARTcell infusion. Findings will contribute to an early warning system for impending toxicity & relapse. #pedcsm

Researchers Find Inherited Genetic Condition Raises Risk of Developing Two Rare Pediatric Cancers Roswell Park’s Dr Kenan Onel leads large international team that sheds light on pineoblastoma and Wilms tumor.

Researchers Find Inherited Genetic Condition Raises Risk of Developing Two Rare Pediatric Cancers
@roswellpark.bsky.social #pedcsm #oncology
www.onclive.com/view/researc...

Kimberly Stegmaier Named as Pediatric Oncology Chair at Dana-Farber Kimberly Stegmaier, MD, was recently named Chair of Pediatric Oncology at Dana-Farber Cancer Institute.

Kimberly Stegmaier Named as Pediatric Oncology Chair at Dana-Farber
@danafarbernews.bsky.social #pedcsm #Oncology
www.onclive.com/view/kimberl...